Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesCochlear Ltd

Cochlear Ltd

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
155.47 AUD 1.03 ( 0.67%)
Last update at 2026-11-06T06:17:00Z
VOLUME
443692
Market Cap
10100.21M
P/E
68.64

Momentum Score

…

Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System; Cochlear Custom Sound Pro Fitting Software; Cochlear Remote Assist; Cochlear Remote Check; and Cochlear Link. It offers its products and services under the Cochlear, Nucleus, Nexa, Osia, and Cochlear Baha brands. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
151.56
Low
155.47
High
52 Week Price Range
87.88
Low
284.78
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Cochlear Ltd designs, manufactures and distributes cochlear implants and related hearing solutions worldwide to surgical centers, audiologists and patients. Long-term growth may be driven by ageing populations and higher implant penetration in under-served markets, recurring revenue from processors and aftercare, and continued product and surgical innovation, while its market leadership and global service network appear positioned to support technology upgrades.
Key risks include regulatory and reimbursement pressures, competition from other implant makers, surgical adoption and pricing constraints, and potential supply-chain or execution issues that could affect product availability.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
154.44
Dividend Yield
2.43%
Revenue TTM
2347.60M
Revenue Per Share
35.89
Gross Profit TTM
1659.60M
Debt / Equity
0.12
ROE
7.98%
Net Debt
25.00M
ROCE
15.06%
Diluted EPS TTM
2.25

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax 201.00M 518.50M 484.80M 396.60M 393.80M
Net income 147.30M 388.90M 356.80M 300.60M 289.10M
Selling general administrative 1022.50M 207.90M 212.60M 203.90M 159.00M
Selling and marketing expenses - 732.00M 685.00M 606.50M 498.70M
Gross profit 1646.70M 1727.90M 1673.50M 1448.10M 1237.30M
Reconciled depreciation 104.70M 90.40M 84.90M 80.90M 73.00M
Ebit 301.00M 529.50M 494.60M 406.00M 402.40M
Ebitda 407.00M 619.90M 579.50M 486.90M 475.40M
Depreciation and amortization 106.00M 90.40M 84.90M 80.90M 73.00M
Operating income 301.00M 406.10M 521.50M 406.30M 380.90M
Other operating expenses 2033.70M 1937.00M 1821.60M 570.60M 426.30M
Interest expense 13.20M 11.00M 9.20M 9.40M 8.60M
Tax provision 66.60M 129.60M 128.00M 96.00M 104.70M
Interest income 10.20M 11.70M 19.00M 7.10M 2.40M
Net interest income -3.00M 0.70M 9.80M 7.10M -6.20M
Income tax expense 53.70M 129.60M 128.00M 96.00M 104.70M
Total revenue 2334.70M 2343.10M 2235.60M 1936.10M 1648.30M
Total operating expenses 1345.70M 1321.80M 1259.50M 1136.20M 941.40M
Cost of revenue 688.00M 615.20M 562.10M 488.00M 411.00M
Total other income expense net -100.00M 112.40M 9.80M -3.30M 31.10M
Net income from continuing ops 147.30M 388.90M 356.80M 300.60M 289.10M
Net income applicable to common shares - 388.90M 356.80M 300.60M 289.10M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 2602.90M 2825.00M 2745.10M 2568.70M 2465.10M
Intangible assets 217.60M 222.20M 193.30M 188.00M 135.40M
Other current assets 62.00M - 44.90M 57.00M 79.00M
Total liab 862.40M 874.70M 904.60M 819.90M 779.40M
Total stockholder equity 1740.50M 1950.30M 1840.50M 1748.80M 1685.70M
Deferred long term liab - - - - 33.00M
Other current liab 226.40M - 220.00M 206.80M 161.80M
Common stock 1176.00M - 1204.20M 1250.30M 1276.60M
Capital stock 1176.00M 1176.00M 1204.20M 1250.30M 1276.60M
Retained earnings 645.70M 777.30M 667.90M 555.40M 455.30M
Other liab - - - 79.30M 76.60M
Good will 265.60M 278.60M 257.70M 256.10M 257.10M
Other assets - - - 126.90M 220.30M
Cash 187.70M 275.70M 513.60M 555.50M 629.30M
Cash and equivalents - - - 555.50M 629.30M
Total current liabilities 604.50M 602.30M 631.50M 578.00M 527.60M
Current deferred revenue 65.50M - 66.70M 61.60M 54.70M
Net debt 25.00M - -269.90M -353.70M -375.40M
Short term debt 42.00M - 41.60M 39.20M 78.70M
Short long term debt - - - - 42.60M
Short long term debt total 212.70M - 243.70M 201.80M 253.90M
Other stockholder equity -9.10M - - -1805.70M -1731.90M
Property plant equipment - - - 447.20M 439.20M
Total current assets 1300.20M 1416.80M 1452.10M 1361.50M 1327.00M
Long term investments 41.10M 78.90M 83.40M 97.30M 119.10M
Net tangible assets - - - 1304.70M 1326.20M
Short term investments - - - 90.80M 68.80M
Net receivables 559.20M 533.80M 502.00M 437.50M 348.50M
Long term debt - - - - 0.00M
Inventory 491.30M 499.40M 391.60M 311.50M 270.20M
Accounts payable 270.60M 298.40M 303.20M 270.40M 232.40M
Accumulated other comprehensive income -72.10M - -31.60M -56.90M -46.20M
Non currrent assets other 11.50M 110.50M 193.30M 93.30M 71.20M
Non current assets total 1302.70M 1408.20M 1293.00M 1207.20M 1138.10M
Capital lease obligations 212.70M 235.70M 243.70M 201.80M 211.30M
Long term debt total - - - 162.60M 175.20M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments -13.80M -115.20M -105.70M -125.70M -61.70M
Change to liabilities - - - 31.80M 89.80M
Total cashflows from investing activities -104.50M -115.20M -105.70M -125.70M -138.90M
Net borrowings 0.00M - - -72.70M -25.60M
Total cash from financing activities -344.10M -366.90M -323.80M -310.40M -220.70M
Change to operating activities - - - 31.90M 8.90M
Net income 147.30M 388.90M 356.80M 300.60M 289.10M
Change in cash -88.00M -237.90M -41.90M -73.80M 19.70M
Begin period cash flow 275.70M 513.60M 555.50M 629.30M 609.60M
End period cash flow 187.70M 275.70M 513.60M 555.50M 629.30M
Total cash from operating activities 368.00M 237.60M 388.80M 362.40M 376.50M
Issuance of capital stock - 0.10M 0.10M - 1.10M
Depreciation 106.00M - 84.90M 71.90M 64.50M
Other cashflows from investing activities - -40.20M -27.40M -29.80M -61.70M
Dividends paid 281.20M -278.20M -245.70M 197.40M 194.00M
Change to inventory 8.00M -107.80M -80.10M -41.30M -54.10M
Change to account receivables 25.30M -101.70M -53.60M -89.00M -52.20M
Sale purchase of stock -26.70M -28.30M -43.00M -29.60M -29.60M
Other cashflows from financing activities -36.20M -60.50M -2.80M -42.10M -25.60M
Change to netincome - - - 23.30M -7.60M
Capital expenditures 61.10M 102.60M 89.80M 95.90M 77.20M
Change in working capital -30.40M -267.20M -74.60M -130.30M -106.30M
Stock based compensation - - - 15.90M 10.80M
Other non cash items 145.10M 504.80M 106.60M -10.10M 22.90M
Free cash flow 306.90M 135.00M 299.00M 266.50M 299.30M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
COH
Cochlear Ltd		 1.03
0.67%		 155.47 68.64 27.40 4.30 5.34 3.97 28.09
IMR
Imricor Medical Systems Inc		 -0.03
2.29%		 1.28 - - 36401.21 17.45 4019.33 -2.60
AVR
Anteris Technologies Global Corp		 -0.36
4.21%		 8.20 - - 356.02 2.19 130.34 -5.20
AVH
Avita Medical Inc		 -0.08
1.73%		 4.55 - 9.97 9.59 7.17 6.76 15.37
PNV
Polynovo Ltd		 -0.01
1.66%		 0.89 90.50 90.91 4.17 6.67 4.08 54.57

Profile*

Cochlear Ltd

Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System; Cochlear Custom Sound Pro Fitting Software; Cochlear Remote Assist; Cochlear Remote Check; and Cochlear Link. It offers its products and services under the Cochlear, Nucleus, Nexa, Osia, and Cochlear Baha brands. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

1 University Avenue, Sydney, NSW, Australia, 2109

61 2 9428 6555

https://www.cochlear.com

5400

Name Title Year Born
Mr. Diggory William Howitt BE (Hons), MBA CEO, MD, Pres & Exec. Director 1967
Mr. Stuart Sayers Chief Financial Officer NA
Mr. Jan Janssen MSc Elec Eng Chief Technology Officer 1965
Mr. Anthony Bishop Pres of Asia Pacific & Latin America NA
Ms. Lisa Aubert Pres of North America NA
Mr. Richard Brook MBA Pres of EMEA NA
Mr. David Hackshall Chief Information Officer NA
Ms. Kristina Devon VP of Investor Relations NA
Ms. Jennifer Stevenson VP of Corp. Communications & Brand NA
Mr. Dean Phizacklea Sr. VP of Global Strategic Marketing NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…